Efficacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: a multicenter, prospective, single-arm, phase 2 trial

BACKGROUND: Pomalidomide in combination with dexamethasone has demonstrated positive results in patients with relapsed or refractory multiple myeloma (RRMM), but no data are available in China. We conducted a multicenter, single-arm trial to examine the efficacy and safety of bioequivalent generic p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Wei-Jun, Wang, Ya-Fei, Zhao, Hong-Guo, Niu, Ting, Fang, Bai-Jun, Liao, Ai-Jun, Bai, Hai, Lu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250185/
https://www.ncbi.nlm.nih.gov/pubmed/35778685
http://dx.doi.org/10.1186/s12885-022-09802-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250185/
https://www.ncbi.nlm.nih.gov/pubmed/35778685
http://dx.doi.org/10.1186/s12885-022-09802-y

Ejemplares similares